Reviva pharmaceuticals to participate in the lytham partners spring 2023 investor conference

Cupertino, calif., may 12, 2023 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), respiratory and metabolic diseases, today announced that it will be participating in the lytham partners spring 2023 investor conference taking place virtually on thursday, may 18, 2023.
RVPH Ratings Summary
RVPH Quant Ranking